Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。